BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 23801138)

  • 1. Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?
    Masaki Y; Nakajima A; Iwao H; Kurose N; Sato T; Nakamura T; Miki M; Sakai T; Kawanami T; Sawaki T; Fujita Y; Tanaka M; Fukushima T; Okazaki T; Umehara H
    J Clin Exp Hematop; 2013; 53(1):79-85. PubMed ID: 23801138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical hyaline vascular-type castleman's disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy.
    Iwaki N; Sato Y; Takata K; Kondo E; Ohno K; Takeuchi M; Orita Y; Nakao S; Yoshino T
    J Clin Exp Hematop; 2013; 53(1):87-93. PubMed ID: 23801139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012).
    Kawabata H; Takai K; Kojima M; Nakamura N; Aoki S; Nakamura S; Kinoshita T; Masaki Y
    J Clin Exp Hematop; 2013; 53(1):57-61. PubMed ID: 23801135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome).
    Kageyama C; Igawa T; Gion Y; Iwaki N; Tabata T; Tanaka T; Kondo E; Sakai H; Tsuneyama K; Nomoto K; Noguchi H; Yoshino T; Yokota K; Sato Y
    Pathol Int; 2019 Oct; 69(10):572-579. PubMed ID: 31631463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report.
    Tedesco S; Postacchini L; Manfredi L; Goteri G; Luchetti MM; Festa A; Gabrielli A; Pomponio G
    Exp Hematol Oncol; 2015; 4(1):3. PubMed ID: 25671135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of multicentric castleman's disease of mixed-type, which showed constellation of symptoms, i.e., thrombocytopenia, anasarca, anemia, fever, myelofibrosis, and lymphadenopathy.
    Awano N; Inomata M; Sonoda Y; Kondoh K; Ono R; Moriya A; Ando T; Kumasaka T; Takemura T; Takeuchi K; Ikushima S
    J Clin Exp Hematop; 2013; 53(1):101-5. PubMed ID: 23801141
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
    Saito H; Tanaka K; Fujiwara M; Iwasaki T; Numata T; Oda A; Kanno M; Tanaka M; Eiro M; Satoh M; Kazama JJ
    CEN Case Rep; 2019 Nov; 8(4):239-245. PubMed ID: 31077056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
    Konishi Y; Takahashi S; Nishi K; Sakamaki T; Mitani S; Kaneko H; Mizutani C; Ukyo N; Hirata H; Tsudo M
    Tohoku J Exp Med; 2015 Aug; 236(4):289-95. PubMed ID: 26250536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report.
    Fujiwara Y; Ito K; Takamura A; Nagata K
    J Med Case Rep; 2018 Oct; 12(1):295. PubMed ID: 30293532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tafro syndrome: Critical review for clinicians and pathologists.
    Paydas S
    Crit Rev Oncol Hematol; 2018 Aug; 128():88-95. PubMed ID: 29958635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?
    Fujimoto S; Sakai T; Kawabata H; Kurose N; Yamada S; Takai K; Aoki S; Kuroda J; Ide M; Setoguchi K; Tsukamoto N; Iwao-Kawanami H; Kawanami T; Mizuta S; Fukushima T; Masaki Y
    Am J Hematol; 2019 Sep; 94(9):975-983. PubMed ID: 31222819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease.
    Nishimura Y; Fajgenbaum DC; Pierson SK; Iwaki N; Nishikori A; Kawano M; Nakamura N; Izutsu K; Takeuchi K; Nishimura MF; Maeda Y; Otsuka F; Yoshizaki K; Oksenhendler E; van Rhee F; Sato Y
    Am J Hematol; 2021 Oct; 96(10):1241-1252. PubMed ID: 34265103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody.
    Kawabata H; Kotani S; Matsumura Y; Kondo T; Katsurada T; Haga H; Kadowaki N; Takaori-Kondo A
    Intern Med; 2013; 52(13):1503-7. PubMed ID: 23812199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporin A : a case report.
    Inoue M; Ankou M; Hua J; Iwaki Y; Hagihara M; Ota Y
    J Clin Exp Hematop; 2013; 53(1):95-9. PubMed ID: 23801140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAFRO Syndrome That Responded to Prednisolone-only Treatment: Evaluating Changes in IL-6.
    Suzuki H; Sano T; Shimasaki Y; Yamaguchi M; Ide T; Arinaga-Hino T; Kuwahara R; Amano K; Oshima K; Nagafuji K; Ida H; Koga H; Torimura T
    Intern Med; 2022 Oct; 61(19):2967-2972. PubMed ID: 35228431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A severe case of thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly syndrome with myocardial and skeletal muscle calcification despite hypocalcemia: a case report.
    Minomo S; Fujiwara Y; Sakashita S; Takamura A; Nagata K
    J Med Case Rep; 2021 Jan; 15(1):3. PubMed ID: 33402219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High proportion of TAFRO syndrome in Thai adult Castleman's disease patients: a 10-year experience.
    Owattanapanich W; Pholmoo W; Pongpruttipan T; Siritanaratkul N
    Ann Hematol; 2018 Jun; 97(6):1019-1026. PubMed ID: 29464312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicentric Castleman's disease in India - Does EBV rather than HHV8 play a role?
    Bhanvadia V; Shet T; Rao V; Epari S; Gujral S; Jain H; Bagal B; Sengar M
    Indian J Pathol Microbiol; 2021; 64(2):302-309. PubMed ID: 33851624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly syndrome: a retrospective study from a large Western cohort.
    Maisonobe L; Bertinchamp R; Damian L; Gérard L; Berisha M; Guillet S; Fieschi C; Malphettes M; Fadlallah J; Hié M; Dunogué B; De Wilde V; Vandergheynst F; Zafrani L; Grall M; Saada N; Garzaro M; Oksenhendler E; Galicier L; Boutboul D
    Br J Haematol; 2022 Feb; 196(3):599-605. PubMed ID: 34585382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAFRO syndrome: 2 cases and review of the literature.
    Kawashima M; Usui T; Okada H; Mori I; Yamauchi M; Ikeda T; Kajita K; Kito Y; Miyazaki T; Fujioka K; Ishizuka T; Morita H
    Mod Rheumatol; 2017 Nov; 27(6):1093-1097. PubMed ID: 26052800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.